← Leaderboards
Johannes Zakrzewski
Hackensack University Medical Center
$2,840,918
Attributed
$2,840,918
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $592.6K · FY2011–25$1M$750K$500K$250K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,840,918 · 2
By mechanism
R37$2,202,507 · 1
K08$638,411 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Signal Transduction”
- Peter B. Gilbert · Fred Hutchinson Cancer Center$148,539,615
- David Heimbrook · Leidos Biomedical Research, Inc.$82,049,940
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$70,290,471
- Garret A Fitzgerald · University Of Pennsylvania$66,142,222
- Michael Barry Kastan · Duke University$64,512,357
- Randall J Bateman · Washington University$62,939,456
Research focus
Signal TransductionPhenotypeDesignIn VitroMalignant NeoplasmsMouse ModelCell LineageClinically RelevantImmunotherapeutic AgentImmunityAllogenicIn VivoIrradiationLaboratoriesCancer PatientCancer TherapyCellsChemotherapyEngraftmentGenerationsHematopoietic Stem CellsHigh RiskBone MarrowT-Cell Development
Grant awards (9)
Harnessing the thymus for long-term tumor control with hematopoietic stem cell-derived naive CAR T cells$539,448
R37 · FY2025 · CA · contact PI
Harnessing the thymus for long-term tumor control with hematopoietic stem cell-derived naive CAR T cells$526,721
R37 · FY2024 · CA · contact PI
Harnessing the thymus for long-term tumor control with hematopoietic stem cell-derived naive CAR T cells$543,694
R37 · FY2023 · CA · contact PI
Harnessing the thymus for long-term tumor control with hematopoietic stem cell-derived naive CAR T cells$592,644
R37 · FY2022 · CA · contact PI
Strategies to enhance thymus-independent T cell development in cancer patients$127,682
K08 · FY2015 · CA · contact PI
Strategies to enhance thymus-independent T cell development in cancer patients$127,682
K08 · FY2014 · CA · contact PI
Strategies to enhance thymus-independent T cell development in cancer patients$127,682
K08 · FY2013 · CA · contact PI
Strategies to enhance thymus-independent T cell development in cancer patients$127,682
K08 · FY2012 · CA · contact PI
Strategies to enhance thymus-independent T cell development in cancer patients$127,683
K08 · FY2011 · CA · contact PI